{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:16:09Z","timestamp":1770329769294,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1136\/annrheumdis-2021-220306","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T17:44:03Z","timestamp":1625247843000},"page":"1475-1482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis"],"prefix":"10.1016","volume":"80","author":[{"given":"Cristina","family":"Ponte","sequence":"first","affiliation":[]},{"given":"Sara","family":"Monti","sequence":"additional","affiliation":[]},{"given":"Carlo Alberto","family":"Scir\u00e8","sequence":"additional","affiliation":[]},{"given":"Paolo","family":"Delvino","sequence":"additional","affiliation":[]},{"given":"Nikita","family":"Khmelinskii","sequence":"additional","affiliation":[]},{"given":"Alessandra","family":"Milanesi","sequence":"additional","affiliation":[]},{"given":"V\u00edtor","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Fabio","family":"Brandolino","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Saraiva","sequence":"additional","affiliation":[]},{"given":"Carlomaurizio","family":"Montecucco","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Wolfgang A","family":"Schmidt","sequence":"additional","affiliation":[]},{"given":"Raashid Ahmed","family":"Luqmani","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2021-220306_bib1","first-page":"1","article-title":"Revised international chapel Hill consensus conference Nomenclature of vasculitides","volume":"2013","author":"Jennette","year":"2012","journal-title":"Arthritis & Rheumatism"},{"key":"10.1136\/annrheumdis-2021-220306_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. trends and clinical spectrum in 161 patients","volume":"79","author":"Gonz\u00e1lez-Gay","year":"2000","journal-title":"Medicine"},{"key":"10.1136\/annrheumdis-2021-220306_bib3","doi-asserted-by":"crossref","first-page":"e3524","DOI":"10.1097\/MD.0000000000003524","article-title":"Flares in biopsy-proven giant cell arteritis in northern Italy: characteristics and predictors in a long-term follow-up study","volume":"95","author":"Restuccia","year":"2016","journal-title":"Medicine"},{"key":"10.1136\/annrheumdis-2021-220306_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MD.0000000000000033","article-title":"Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients","volume":"93","author":"Alba","year":"2014","journal-title":"Medicine"},{"key":"10.1136\/annrheumdis-2021-220306_bib5","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3899\/jrheum.141347","article-title":"Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study","volume":"42","author":"Kermani","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2021-220306_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/kev348","article-title":"Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study","volume":"55","author":"Labarca","year":"2016","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MD.0b013e31821c4fad","article-title":"Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain","volume":"90","author":"Martinez-Lado","year":"2011","journal-title":"Medicine"},{"key":"10.1136\/annrheumdis-2021-220306_bib8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/rheumatology\/39.10.1089","article-title":"Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases","volume":"39","author":"Liozon","year":"2000","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2021-220306_bib10","first-page":"S30","article-title":"Giant cell arteritis: intensity of the initial systemic inflammatory response and the course of the disease","volume":"26","author":"Nesher","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2021-220306_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art1.10161","article-title":"A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis","volume":"47","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2021-220306_bib12","first-page":"171","article-title":"Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis","volume":"19","author":"Hachulla","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2021-220306_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.282.6260.269","article-title":"Prognosis in giant-cell arteritis","volume":"282","author":"Graham","year":"1981","journal-title":"Br Med J"},{"key":"10.1136\/annrheumdis-2021-220306_bib14","doi-asserted-by":"crossref","first-page":"e001003","DOI":"10.1136\/rmdopen-2019-001003","article-title":"Systematic literature review Informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis","volume":"5","author":"Monti","year":"2019","journal-title":"RMD Open"},{"key":"10.1136\/annrheumdis-2021-220306_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/pgmj.74.867.1","article-title":"Assessment of disease activity in systemic vasculitis","volume":"74","author":"Tse","year":"1998","journal-title":"Postgrad Med J"},{"key":"10.1136\/annrheumdis-2021-220306_bib16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/art.40876","article-title":"Glucocorticoid dosages and Acute\u2010Phase reactant levels at giant cell arteritis flare in a randomized trial of tocilizumab","volume":"71","author":"Stone","year":"2019","journal-title":"Arthritis & Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2021-220306_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2474-11-44","article-title":"The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis","volume":"11","author":"Arida","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1136\/annrheumdis-2021-220306_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-142-5-200503010-00011","article-title":"Meta-Analysis: test performance of ultrasonography for giant-cell arteritis","volume":"142","author":"Karassa","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2021-220306_bib20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/bjs.7252","article-title":"Role of ultrasonography in the diagnosis of temporal arteritis","volume":"97","author":"Ball","year":"2010","journal-title":"Br J Surg"},{"key":"10.1136\/annrheumdis-2021-220306_bib21","doi-asserted-by":"crossref","first-page":"e000612","DOI":"10.1136\/rmdopen-2017-000612","article-title":"Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis Informing the EULAR recommendations","volume":"4","author":"Duftner","year":"2018","journal-title":"RMD Open"},{"key":"10.1136\/annrheumdis-2021-220306_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2018.07.012","article-title":"Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature","volume":"18","author":"Rinagel","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2021-220306_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2021-220306_bib24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"10.1136\/annrheumdis-2021-220306_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.40044","article-title":"A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis","volume":"69","author":"Langford","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/annrheumdis-2021-220306_bib26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2021-220306_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/kex173","article-title":"The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist","volume":"57","author":"Monti","year":"2018","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/rheumatology\/kex341","article-title":"The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice","volume":"57","author":"Monti","year":"2018","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0033-1335143","article-title":"EFSUMB minimum training requirements for rheumatologists performing musculoskeletal ultrasound","volume":"34","author":"Terslev","year":"2013","journal-title":"Ultraschall Med"},{"key":"10.1136\/annrheumdis-2021-220306_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/annrheumdis-2018-213102","article-title":"Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis","volume":"77","author":"Quinn","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2021-220306_bib32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/key015","article-title":"Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis","volume":"57","author":"Reichenbach","year":"2018","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib33","first-page":"S34","article-title":"The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis","volume":"30","author":"De Miguel","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2021-220306_bib34","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/rheumatology\/key383","article-title":"Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study","volume":"58","author":"Aschwanden","year":"2019","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib35","first-page":"S77","article-title":"Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis","volume":"27","author":"P\u00e9rez L\u00f3pez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2021-220306_bib36","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1136\/annrheumdis-2019-216527","article-title":"Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?","volume":"80","author":"Evangelatos","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2021-220306_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-011-1808-0","article-title":"Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis","volume":"31","author":"Habib","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2021-220306_bib38","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/rheumatology\/ken258","article-title":"Prognosis of large-vessel giant cell arteritis","volume":"47","author":"Schmidt","year":"2008","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/rheumatology\/kes239","article-title":"Outcome of giant cell arteritis of the arm arteries managed with medical treatment alone: cross-sectional follow-up study","volume":"52","author":"Czihal","year":"2013","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib40","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/ard.2009.122135","article-title":"Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions","volume":"69","author":"Aschwanden","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2021-220306_bib41","article-title":"B-Mode sonography wall thickness assessment of the temporal and axillary arteries for the diagnosis of giant cell arteritis: a cohort study","volume":"6","author":"Czihal","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2021-220306_bib42","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/rheumatology\/kex143","article-title":"Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis","volume":"56","author":"Sch\u00e4fer","year":"2017","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib43","first-page":"kez554","article-title":"The impact of disease extent and severity detected by quantitative ultrasound analysis in the diagnosis and outcome of giant cell arteritis","author":"Monti","year":"2019","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/annrheumdis-2019-216343","article-title":"Novel ultrasonographic halo score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia","volume":"79","author":"van der Geest","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2021-220306_bib45","doi-asserted-by":"crossref","first-page":"1346-1352","DOI":"10.1093\/rheumatology\/keaa578","article-title":"The cut-off values for the intima-media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries","volume":"60","author":"Je\u0161e","year":"2021","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib46","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/kes153","article-title":"Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis","volume":"51","author":"Hauenstein","year":"2012","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib47","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/rheumatology\/kes387","article-title":"Temporal ultrasonography findings in temporal arteritis: early disappearance of halo sign after only 2 days of steroid treatment","volume":"52","author":"Santoro","year":"2013","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib48","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/rheumatology\/keaa196","article-title":"Early variation of ultrasound halo sign with treatment and relation with clinical features in patients with giant cell arteritis","volume":"59","author":"Ponte","year":"2020","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/rheumatology\/kes239","article-title":"Outcome of giant cell arteritis of the arm arteries managed with medical treatment alone: cross-sectional follow-up study","volume":"52","author":"Czihal","year":"2013","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2021-220306_bib50","first-page":"107","article-title":"Follow-Up vascular ultrasounds in patients with giant cell arteritis","volume":"38 Suppl 124","author":"Ford","year":"2020","journal-title":"Clin Exp Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724095384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724095384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2021-220306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:00:45Z","timestamp":1737349245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724095384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0003496724095384"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2021-220306","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2021-220306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 \u00a9 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}